InflaRx N.V. (IFRX) stock
IFRXNasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.11−0.04 (-3.48%)
Close on Nov 18, 2026Market cap $80.25MP/E –Yield –
InflaRx revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
For fiscal 2025 it was €29.33K, down 82.3% from the year before.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | €29.33K | -82.3% |
| FY2024 | Dec 31, 2024 | €165.79K | +162.8% |
| FY2023 | Dec 31, 2023 | €63.09K | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2025 | Jun 30, 2025 | €39.43K | – |
| Q2 FY2024 | Jun 30, 2024 | €6.36K | – |
See a number that looks wrong?